id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ffhd-41	Hsieh, Wen-Chuan; Yang, Ching-Wen; Haung, Yi-Sheng; Chao, Ting-Wei; Tsai, Tin-Fen; Su, Ih-Jen	Chemoprevention of HBV-related hepatocellular carcinoma by the combined product of resveratrol and silymarin in transgenic mice	2013		.htm	text/html	650	19	23	No. 9 (2013): September 2013 / Research Articles Chemoprevention of HBV-related hepatocellular carcinoma by the combined product of resveratrol and silymarin in transgenic mice Authors Wen-Chuan Hsieh National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan Ching-Wen Yang Institute of Basic Medical Research, National Cheng Kung University Medical School, Tainan Yi-Sheng Haung National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan Ting-Wei Chao National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan Tin-Fen Tsai Faculty of Life Sciences and Institute of Genetics, National Yang-Ming University, Taipei Ih-Jen Su National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan DOI: https://doi.org/10.31989/ffhd.v3i9.41 Abstract Background: Patients with chronic hepatitis B virus (HBV) infection are at a high risk to develop hepatocellular carcinoma (HCC). Conclusions: The combined silymarin and resveratrol product exhibits a synergistic effect on the reduction of HCC development in transgenic mice model and may represent a potential agent for the prevention of HCC in high risk chronic HBV carriers.	cache/ffhd-41.htm	txt/ffhd-41.txt